A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

← catalyst calendar

NCT06604039 · readout in 3,032 d

Sponsored by Teleflex (industry) · TFX — their whole pipeline →.

Phase

—

Status

Recruiting

Study type

Observational

Enrollment

2,500estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2024-12-08

actual

When the study began enrolling

Primary completion

2034-12-07

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2034-12-07

estimated

The whole study's end, after follow-up

First posted

2024-09-19

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-08-11

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

Vascular Access Device

Intervention

Device: Central venous catheter — also filed as Peripherally inserted central catheter, Dialysis catheter, Midline intravenous catheter, Peripheral intravenous catheter, Arterial catheter, Catheter navigation/tip confirmation device

Primary outcomes

what the primary-completion date above is the date OF

Catheter devices: successful use of the device without removal due to device-related adverse events

measured Within 7 days after subject device removal

Arrow VPS Rhythm DXL catheter tip positioning system: Successful verification of catheter tip location

measured Immediately after subject device removal

Permalink · TFX's whole pipeline · Catalyst calendar · Every registered study · What changed